Search research articles
Contact Us
Filters
Showing results (191-200 of 203) with videos related to
Page
of 21
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice
|
June 24, 2021
Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review
Theo Gülen, Cem Akin, Patrizia Bonadonna, et al.
Circulation. Arrhythmia and Electrophysiology
|
September 8, 2022
Sinus Tachycardia: a Multidisciplinary Expert Focused Review
Kenneth A Mayuga, Artur Fedorowski, Fabrizio Ricci, et al.
The Journal of Allergy and Clinical Immunology
|
April 15, 2026
Avapritinib achieves long-term disease control with favorable safety in patients with indolent systemic mastocytosis over 3 years
Cem Akin, Vito Sabato, Jason Gotlib, et al.
The Journal of Allergy and Clinical Immunology
|
October 19, 2015
Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology
Karin Hartmann, Luis Escribano, Clive Grattan, et al.
Hemasphere
|
December 13, 2021
Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal
Peter Valent, Cem Akin, Karin Hartmann, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
July 1, 2022
Mast Cell Diseases in Practice and Research: Issues and Perspectives Raised by Patients and Their Recommendations to the Scientific Community and Beyond
Susan V Jennings, Celeste C Finnerty, Jessica S Hobart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 27, 2014
Hematopoietic stem-cell transplantation for advanced systemic mastocytosis
Celalettin Ustun, Andreas Reiter, Bart L Scott, et al.
International Journal of Laboratory Hematology
|
September 14, 2020
Core-binding factor acute myeloid leukemia with inv(16): Older age and high white blood cell count are risk factors for treatment failure
Celalettin Ustun, Elizabeth A Morgan, Ethan M Ritz, et al.
Cancer Medicine
|
August 18, 2018
Core-binding factor acute myeloid leukemia with t(8;21): Risk factors and a novel scoring system (I-CBFit)
Celalettin Ustun, Elizabeth Morgan, Erica E M Moodie, et al.
Blood Advances
|
May 18, 2021
Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21)
Se Young Han, Krzysztof Mrózek, Jenna Voutsinas, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 203) with videos related to
Sort By:
Page
of 21
The Journal of Allergy and Clinical Immunology. in Practice
|
June 24, 2021
Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review
Theo Gülen, Cem Akin, Patrizia Bonadonna, et al.
Circulation. Arrhythmia and Electrophysiology
|
September 8, 2022
Sinus Tachycardia: a Multidisciplinary Expert Focused Review
Kenneth A Mayuga, Artur Fedorowski, Fabrizio Ricci, et al.
The Journal of Allergy and Clinical Immunology
|
April 15, 2026
Avapritinib achieves long-term disease control with favorable safety in patients with indolent systemic mastocytosis over 3 years
Cem Akin, Vito Sabato, Jason Gotlib, et al.
The Journal of Allergy and Clinical Immunology
|
October 19, 2015
Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology
Karin Hartmann, Luis Escribano, Clive Grattan, et al.
Hemasphere
|
December 13, 2021
Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal
Peter Valent, Cem Akin, Karin Hartmann, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
July 1, 2022
Mast Cell Diseases in Practice and Research: Issues and Perspectives Raised by Patients and Their Recommendations to the Scientific Community and Beyond
Susan V Jennings, Celeste C Finnerty, Jessica S Hobart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 27, 2014
Hematopoietic stem-cell transplantation for advanced systemic mastocytosis
Celalettin Ustun, Andreas Reiter, Bart L Scott, et al.
International Journal of Laboratory Hematology
|
September 14, 2020
Core-binding factor acute myeloid leukemia with inv(16): Older age and high white blood cell count are risk factors for treatment failure
Celalettin Ustun, Elizabeth A Morgan, Ethan M Ritz, et al.
Cancer Medicine
|
August 18, 2018
Core-binding factor acute myeloid leukemia with t(8;21): Risk factors and a novel scoring system (I-CBFit)
Celalettin Ustun, Elizabeth Morgan, Erica E M Moodie, et al.
Blood Advances
|
May 18, 2021
Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21)
Se Young Han, Krzysztof Mrózek, Jenna Voutsinas, et al.
Page
of 21